The aims of this study were to examine long-term survival in a population-based sample of spinal cord injury (SCI) survivors in Great Britain, identify risk factors contributing to deaths and explore trends in cause of death over the decades following SCI. Current survival status was successfully identi®ed in 92.3% of the study sample. Standardised mortality ratios (SMRs) were calculated and compared with a similar USA study. Relative risk ratio analysis showed that higher mortality risk was associated with higher neurologic level and completeness of spinal cord injury, older age at injury and earlier year of injury. For the entire ®fty year time period, the leading cause of death was related to the respiratory system; urinary deaths ranked second followed by heart disease related deaths, but patterns in causes of death changed over time. In the early decades of injury, urinary deaths ranked ®rst, heart disease deaths second and respiratory deaths third. In the last two decades of injury, respiratory deaths ranked ®rst, heart related deaths were second, injury related deaths ranked third and urinary deaths fourth. This study also raises the question of examining alternative neurological groupings for future mortality risk analysis.
Introduction
Long-term survival following spinal cord injury (SCI) has received a great deal of attention in recent years. An excellent review of the literature and comprehensive study of SCI survival using data from the US Spinal Cord Injury Model Systems 1 describes the changes over the past 20 years in survival and causes of death. The majority of previous studiues have been limited by sample selection biases, 2,3 the inclusion of early posttraumatic deaths, 2, 4, 5 and fairly short follow-up periods, 6 while a few studies have addressed survival in the third and fourth decades following injury. 2, 7, 8 The aims of this study were to examine long-term survival in a population based sample of SCI survivors in Great Britain, identify risk factors contributing to deaths and explore trends in cause of death over the decades following spinal cord injury. This investigation, covering 50 years of spinal cord injury experience, is the longest follow-up SCI survival study to date. Results are compared with SCI mortality data from the United States.
Subjects and identi®cation methods
The inclusion criteria for this survival study selected individuals seen for initial treatment and rehabilitation within one year of injury at the two oldest spinal injuries centres in Great Britain ± the National Spinal Injuries Centre at Stoke Mandeville Hospital in Aylesbury, England, and the Regional Spinal Injuries Centre in Southport, England. Those included had to have sustained traumatic spinal cord injuries prior to January 1 1991 and survived at least 1 year following injury. Study eligibility was further limited to those individuals whose residence at the time of injury was within a speci®ed 17 county catchment area of the two spinal centres. This geographic restriction helped ensure that the sample was population based, and also increased the likelihood that subjects utilized one of the two centres for their on-going follow-up care.
A review of the medical records from both centers con®rmed that 3179 individuals met these study criteria. This included 835 individuals reported in a previous study 7 and added 2344 for the current analysis. The demographic characteristics of this population are shown in Table 1 . Since the study spans nearly ®ve decades, demographic data are given for each decade and for the total population. Approximately 81% of this population are male and 19% female, which is similar to the gender distributions from the US National SCI Database (82.2% and 17.8%) 9 . Age distributions at the time of injury are also shown in Table 1 . Population based studies demonstrate that SCI occurs most frequently in young adults. 10 A similar pattern was noted in this study, and the distribution closely mirrors age at injury patterns in the US.
For the analyses, individuals were categorized into four neurologic groups, based on functional capabilities. Frankel 11 classi®cations A, B and C include individuals with little or no useful muscle power below their injury sites. Frankel D and E indicate that individuals have useful or full recovery of muscles below their injury. Those with Frankel D or E classi®cations, whether they have injuries at the cervical, thoracic or lower levels, tend to have more similar functional abilities. In addition, those with tetraplegia were divided into`high' and`low' groupings, as their functional abilities are markedly dierent and previous research 1 has shown signi®cant differences in survival as well. Therefore, this study sample has been grouped as follows: tetraplegia C1 ± C4 ABC; tetraplegia C5 ± C8 ABC; paraplegia ABC; and all D's (there were no individuals classi®ed as Frankel E by the time of initial discharge in this study). The percentages of individuals in each of these groups are given in Table 1 .
In order to determine survival status, the records of the two spinal units were extensively reviewed. In all cases, the full name, date of birth, place of birth, last known address, death date (if applicable) and National Health Service identi®cation numbers (when available) were extracted. These data were then submitted to the National Health Service Oce of Population Censuses and Surveys (OPCS). 12 In cases where death was already known or subsequently con®rmed by the OPCS search, the OPCS was requested to furnish a copy of each individual's death certi®cate to verify the cause of death. To con®rm survival of individuals presumed to be alive and not being routinely followed at the spinal centers, the OPCS was able to identify the Family Health Service Authority (FHSA) in which the individual was last known to be registered. A letter for each individual living in a particular FHSA was then sent to that FHSA for distribution to their respective family doctor. Each letter requested that the doctor contact the research team to con®rm survival of each individual. These extensive follow-up procedures yielded a 92.3% success rate in identifying current survival status. The OPCS was unable to trace some individuals due to reasons as varied as institutionalization in mental health facilities, emigration from the United Kingdom, or non-registration with a family doctor. The survival status of these cases, who represent 7.7% of the study sample, could not be determined. However, these currently untraceable individuals are included in the following analyses, classi®ed as having withdrawn from the study at the time of their last known date alive. This enables the follow-up period for which the individual was known to be alive to contribute to the survival experience.
Mortality analysis
Comparison to general population Mortality rates of the SCI study population are compared to the general population by calculating Standardized Mortality Ratios (SMRs). SMR is de®ned as actual mortality in a study population divided by the expected mortality in the general population over an equivalent follow-up time period. Since mortality rates are based on gender, age and calendar year (1943 ± 1992) , the expected mortality is calculated by matching each SCI subject to the general population by these factors. Age and gender speci®c mortality rates for the general population were obtained from the Oce of Population Censuses and Surveys. Expected survival over the entire follow-up interval was cumulated by multiplying the expected yearly survival probabilities over the follow-up interval in accordance with standard actuarial practices. 13 Expected mortality over the entire follow-up period was then calculated as 1.0 minus the cumulated expected survival rate. For those calendar years in which the subject's follow-up did not include the full year, adjustments were made to the yearly survival probabilities to re¯ect the partial year mortality probability. These individual survival probabilities were aggregated by neurologic group to yield group SMRs. An SMR of 1.0 indicates that the SCI group has identical survival to the general population. An SMR greater than 1.0 indicates that the mortality rate in the SCI group is greater than the general population. For example, an SMR of 2.0 suggests that mortality rate in the SCI population is twice that of the general population, while an SMR of 4.0 suggests that four times as many deaths occurred in the SCI population than expected in the general population. Table 2 provides the SMRs by neurologic injury group and age group for the entire sample. Ninety®ve percent con®dence intervals are given for each SMR.
14 Table 3 shows the SMRs by age and neurologic injury group for those subjects injured in 1973 or later. This table is provided to re¯ect the most recent mortality history, and allows direct comparison to the previously cited US study, since the same followup time frame and inclusion criteria of one year survival were used. Predicted life expectancy SMRs can also be used to estimate the remaining years of life for an individual with SCI. Actuarial methods were employed to predict remaining years of life for the general population and SCI population. 13 Yearly mortality probabilities were assigned using the gender and age speci®c mortality rates for 1992, the most recent year for which OPCS data was available. Each yearly mortality rate was multiplied by the appropriate age and injury group SMR to determine the annual predicted mortality for the group of interest. The SMRs based on injuries occurring in 1973 or later were used since they re¯ect the most recent mortality experience and are consistent with the methodology used in the US study. Annual survival probabilities were cumulated in the same manner as in the calculation of the SMRs resulting in the conditional probability of survival to a particular year given that the subject had survived over the previous years. Predicted life expectancy was calculated as the sum of the annual conditional survival probabilities up to the point where additional survival was negligible. Because the SMRs for the C1 ± C4 ABC and C5 ± C8 ABC groups were similar and the number of subjects in these groups were relatively small, it was decided to combine these groups resulting in SMRs of 8.31, 5.41, 4.33 and 3.65 for the age groups 0 ± 30, 31 ± 45, 46 ± 60 and 61+ respectively. To overcome the instability of the SMRs, smoothing techniques were applied using a 3rd degree polynomial regression to reduce variations attributable to the instability of the SMRs. Gender speci®c predicted life expectancies are plotted in Figures 1 and 2 . Table 4 lists the smoothed values of remaining years of life.
Cox regression
Cox proportional hazards regression was performed to assess the in¯uence of predictor variables (in the presence of other predictors) on survival. 15 The main purpose of this analysis was to quantify the improvement in survival over the 50 year span of the study. Because the amount of follow-up for an individual is a function of the year the individual was injured, ®ve subgroup analyses were performed to ensure consistency of the risk ratios over time. The ®rst sub-analysis included all individuals and spanned the ®rst 10 years of follow-up for each individual. The second subanalysis spanned the ®rst 20 years of follow-up and excluded individuals injured in the most recent decade 1983 ± 1990, since they were not eligible for a full 20 years of follow-up. The remaining sub-analyses were constructed in a similar manner comparing only those individuals with equivalent follow-up times. The results of these sub-analyses exhibited consistent risk ratios over time indicating that a single analysis spanning all 50 years of follow-up was appropriate and that the assumptions of proportional hazards over time were Table 5 .
Causes of death
Over the time span of the study, causes of death have demonstrated changing trends. The leading causes for the entire time period, the ®rst three decades of injury, and the ®nal two decades of injury are shown in their respective rank orders in Table 6 . There has been a shift away from the predomination of traditional urinary system causes of death in the early years of SCI rehabilitation and follow-up. Pneumonia, influenza, and other respiratory diseases lead in the latter time period, however, it should be noted that the term pneumonia' may be indicated on death certi®cates in the absence of an autopsy and another de®nitive cause of death. Furthermore, injuries (including suicide) account for a larger proportion of the deaths among those injured in the latter two decades.
To determine which factors are predictive of speci®c causes of death, the three leading causes of death were subjected to Cox proportional hazards regression. Tables 7, 8 and 9 list the results for respiratory, urinary system and heart disease. For each of these analyses, individuals who had died from a cause other than that for which the regression is calculated are treated as censored observations (alive). *Analysis of high tetraplegia (C1-C4 ABC) versus low tetraplegia (C5-C8 ABC) showed no signi®cant dierence in mortality (p-0.7763) and were therefore combined. The risk ratios for high and low tetraplegia compared to the Frankel Ds were 2.13 and 2.24 respectively {Dierences in the two SCI centres existed only in the ®rst two decades of injury Neurologic injury level and age at injury are signi®cant predictors for pneumonia, in¯uenza and other respiratory diseases. Individuals with tetraplegia and paraplegia are 4.67 and 2.07 times more likely to die from these causes than individuals classi®ed as Frankel D injured at the same age. Since the risk associated with age at injury is not constant from one age to the next, age at injury was divided into four categories. Individuals injured at ages 31 ± 45 are 4.87 times more likely to die from these causes than those injured at age 30 and under. The risk is almost quadrupled for those injured at ages 46 ± 60 compared to those aged 31 ± 45 of the same neurologic injury level. The group with the highest risk of dying from respiratory diseases are those individuals injured at age 61 or older. Their risk is approximately 46 times greater than those injured at age 30 or younger. The eect of injury year was not statistically signi®cant, suggesting that the risk of dying from these causes has remained relatively constant over the last 50 years.
With regard to urinary diseases, males are 75% more likely to die of urinary system diseases than females. Neurologic injury level is also predictive of urinary system diseases; those with tetraplegia and paraplegia are 4.35 and 2.20 times more likely to die from these causes than individuals classi®ed as Frankel D. The risk associated with age at injury is 5% higher per year. This equates to a 67% increased risk over a ten year period indicating that individuals injured at older ages are more at risk of dying of urinary system diseases. The risk associated with each earlier decade of injury is 2. (10) 44 (5) 32 (4) 57 (6) 33 (4) 20 (2) 75 (8) 1 2 3 4 7 9 6 8 10 5
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76 (34) 21 (9) 28 (12) 19 (8) 12 (5) 15 (7) 22 (10) 10 (4) 3 (1) 20 (9) 1 4 2 6 8 7 3 9 10 5 risk of dying from urinary system diseases was more than halved in each subsequent decade. A protective eect is associated with Stoke Mandeville; the risk of dying of urinary system diseases is 41% lower than those treated at Southport. Data regarding dierences in method of bladder management at the two centres were not available for this study.
The results of the Cox regression for death due to heart disease shows males have a 64% greater risk of dying than females injured at the same age and in the same decade. Age at injury is a signi®cant predictor of heart disease deaths showing that individuals injured at older ages are more at risk. Individuals injured at ages 31 ± 45 are 3.04 times more likely than those injured at age 30 or younger. Similarly, those injured at ages 46 ± 60 and 60+ are 10.18 and 39.00 times more likely to die of heart disease than those aged 30 and younger. The risk for individuals injured in each earlier decade is 37% higher than for the following decade. Using 1983 ± 1990 as the reference decade yields the following risk ratios:
Discussion
With improved emergency medical techniques at the scene of automobile crashes and industrial accidents, immediate survival for people with SCI has improved, thus enabling more indidivuals to be transferred for rehabilitation to specialized SCI treatment centres. In addition, survival for the ®rst year has improved due to advances in medical care over the past 50 years. However, even with improved emergency medical treatment and sophisticated rehabilitation, the general mortality rates of individuals with SCI exceed those of an age-matched non-disabled population. There are slight improvements when evaluating SMRs in the last two decades (1973 ± 1991) and British ratios are essentially comparable to US data.
In this study, the slight increase in mortality of the C5 ± C8 ABC group compared to the C1 ± C4 ABC group may be explained by the inclusion criteria requiring that a person had survived the ®rst year post injury, and that the vast majority in the latter group (90%) are individuals with C-4 level injuries. Furthermore, the C1 ± C4 ABC group is, as expected, considerably smaller than the other neurologic groups, partly due to the increased mortality for individuals with high cervical lesions during their ®rst year following injury. The ®ndings would seem to indicate that there is no dierence in the mortality rates of the C1 ± C4 and C5 ± C8 ABC injury groups, given the individual has survived the ®rst year post injury.
The further decreased sample size of the C1 ± C4 sub-group with injury years 1973 ± 1991 results in less stability of the SMRs. In particular, the extremely low SMR for those aged 31 ± 45 is most likely attributable to the smaller number of subjects (n=21) comprising this group. Because of this small group size, the SMR is very sensitive to the actual number of deaths. For example, if two individuals in the 31 ± 45 year old C1 ± 4 group had died, the SMR would be 3.51; three deaths would have resulted in an SMR of 5.26.
In comparison to the US study, the SMRs are equivalent (within 95% con®dence limits) for all cells with the following exceptions. The SMR for the C1 ± C4 ABC neurologic group aged 31 ± 45 is signi®cantly lower than that reported in the US study and, as discussed previously, could be explained by the small number of individuals in that group. The SMRs for the C5 ± C8 ABC group aged 0 ± 30 and Frankel D group aged 31 ± 45 are signi®cantly higher than the US SMRs.
The eects of gender, neurologic injury classification, age at injury and decade of injury are signi®cant determinants of mortality. Males are 23% more likely to die than females of the same injury age, injury year, neurologic injury level and SCI treatment centre. While analysis of high tetraplegia (C1 ± 4 ABC) versus low tetraplegia (C5 ± 8 ABC) shows no signi®cant dierence in mortality, individuals with tetraplegia and paraplegia are 2.22 and 1.46 times more likely to die than those with very incomplete injuries, Frankel D classi®cation, controlling for other variables in the model. Furthermore, for each year of advancing age at injury, an individual is 7% more likely to die than if he or she was injured`a year younger'. This translates to almost a twofold increase in mortality risk with each advancing decade of age at injury. That is, individuals with SCI have better survival outcomes if they are injured at earlier ages. Using the most recent decade of injury (1983 ± 1990) as the reference decade, individuals injured in the previous decade were 1.50 times more likely to die than had they been injured in 1983 ± 1990. This represents a considerable improvement in survival in the last 10 years. Comparing the ®rst decade of injury (1943 ± 1952) to the most recent represents a reduction in mortality of 71% and 82% over 50 years, depending on the centre in which the individual was treated.
It should be noted that the Cox regression only compares subjects in the study population and does not make inferences to the general population. Therefore, it is dicult to identify the eects of gender, age and decade experienced by the general population. Using gender as an example, in the general population males have poorer survival than females of the same age. The Cox regression does not distinguish between the magnitude of the eect experienced by the general population and the incremental eect experienced by the SCI population. Reporting cause-speci®c SMRs could be attempted, however, due to the small number of deaths in the study, further breakdown into age, duration of injury, gender and neurologic groups would result in unstable SMRs.
The cause-speci®c Cox regressions also warrant further explanation. In particular, neurologic status was not a signi®cant predictor of heart disease, while it was a risk factor for both urinary and respiratory diseases. Due to the low incidence of both ischaemic and non-ischaemic conditions, these were combined, and it is possible that this resulted in negating the eect of neurologic status. For example, if ischaemic heart disease has a greater impact on individuals with more neurologically incomplete injuries and nonischaemic conditions are experienced more frequently by those with complete injuries, neurologic status would not be a signi®cant predictor of death due to heart disease.
It would appear that respiratory and injury related deaths are on the increase in the latter decades. In fact, the actual death rates for these causes are declining, and can be veri®ed by calculating the cause-speci®c mortality rates (deaths/N at risk) for each time period. Dierent exposure times for those in the early versus the latter decades may also account for the apparent shifting pattern in causes of death. As previously demonstrated, the Cox regression for respiratory deaths does not show duration of injury to be a predictive factor.
Life expectancy is important data to both clinicians, SCI survivors, and insurance companies. Accurate assessments of projected life expectancy following injury are dicult to make, and must take into consideration several intangible factors, such as family history, potential health problems, availability of appropriate and adequate health care services, and the every day risks of further injury or death due to accidents or illness, faced by all individuals. In this investigation, dierences in the age and gender distributions that exist across the neurologic injury groups are not taken into consideration in the computation of life expectancies. For example, there are more young males in the group with high tetraplegia and more older females in the group with paraplegia.
The SMRs for the individuals with tetraplegia C1 ± 4 ABC and life expectancy curves for the group with tetraplegia must be interpreted with caution. These data contain very few cases of individuals who may be dependent on mechanical respiration, and the SMRs are likely to be low estimates. In addition, the life expectancies for this group are substantially more optimistic than what both the available literature 16 and clinical experience indicate for individuals requiring the use of mechanical respiration.
Caution also should be exercised in interpreting the predicted life expectancies. An assumption that mortality in the general population will remain constant in the future is inherent in the calculation of life expectancies since they are based solely on 1992 mortality data. The ®gures also do not incorporate the possibility of any current and future medical advances that would improve the survival of individuals with SCI. In addition, gender speci®c SMRs were not calculated due to limited size of the study population. Although gender speci®c life expectancies are given, they are based on SMRs that ignore gender (as there were too few women in the study sample to calculate accurate SMRs) and are instead based on gender speci®c mortality rates in the general population. The analyses were performed for this study to allow comparison to the US data. 1 However, earlier research by the authors 7 with a smaller sample demonstrated that SMRs should not be held constant over time as they actually decrease with duration of injury and age. Further analysis of this larger sample is planned which will incorporate both age and duration of injury in calculating mortality ratios to determine life expectancy.
Finally, the lack of dierences in mortality rates between individuals with C1 ± 4 tetraplegia and those with C5 ± 8 tetraplegia are inconsistent with clinical experience. Further analysis examining the eect of dierent neurologic classi®cation schemes for mortality risk analysis appears warranted. In fact, the authors have conducted additional research to address this issue. 17 The present study suggests that the outlook for longer life expectancy following SCI is improving with each passing decade. Future mortality research to evaluate further changes as individuals survive into their fourth, ®fth and later decades post-injury will be necessary to identify continued dierences from the general population and changing patterns in causes of death.
